QA: AYTU BIOPHARMA INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385818_2023_AYTU_BIOPHARMA_INC.pdf

Logs

Graph

Absolute values for 0001385818, AYTU BIOPHARMA INC

  xvar xval
0 AssetsCurrent 59,929,000
1 IntangibleAssetsNetIncludingGoodwill 70,632,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 7,062,000
4 LiabilitiesCurrent 64,442,000
5 LiabilitiesNoncurrent 12,810,000
6 remainder_Liabilities 14,279,000
7 CostOfGoodsAndServicesSold 44,386,000
8 SellingGeneralAndAdministrativeExpense 31,167,000
9 ResearchAndDevelopmentExpense 14,439,000
10 remainder_Expenses 118,128,000
11 remainder_Revenues 96,669,000
12 remainder_NetIncome 1,278,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 137,623,000
1 Liabilities 91,531,000
2 Expenses 208,120,000
3 Revenues 96,669,000
4 StockholdersEquity 46,092,000
5 NetIncome -110,173,000
6 ComprehensiveNetIncome -110,173,000
7 BaseVar 267,610,500
8 EconomicCapitalRatio -0.270

Edgar->Model Mapping

Feature Distribution

Change over Time